The Korea Consumer Agency has urged the Ministry of Food and Drug Safety (MFDS) to re-evaluate the use of aloe vera whole leaf extract in health functional foods, cliaming long-term use could lead to side-effects, such as decreased colon function.
Novel food product development is rapidly outpacing regulation and consumer understanding, with experts calling for better communication and policy advances to ensure innovation leads to commercialisation.
South Korea’s Ministry of Food and Drug Safety (MFDS) will continue with its high profile crackdown on non-compliant probiotic and krill oil products, with a market expert telling us it is ‘no coincidence’ that these categories remain in the spotlight.
Developing functional foods that deliver health benefits to support the population’s immune and nutrition status is important in the battle against COVID-19, says an ex-policy expert from the Philippines.
Industry stakeholders anticipated a smooth working relationship with a new Biden Administration, but said this year’s highly unusual circumstances makes this transition more uncertain than most.
Australia’s recent bill amendment on the country-of-origin labelling will provide “long-term certainty” for supplements that meet the requirements to make the coveted ‘Made in Australia’ claim, said an industry body.
Australia’s supplements industry body has described the Therapeutic Goods Administration’s (TGA) decision to class certain sports nutrition products as listed products as an over-regulation, adding that this will result in higher production costs which...
The Chinese authorities has opened a public consultation to consider the use of milk minerals and a particular bacteria species as novel food raw materials.
Both local Chinese and foreign infant nutrition brands in China are urged to “push hard on safety cues and messages” in light of the recent infant nutrition scandal happening in the country, according to an industry expert.
China is stepping up its compliance checks on food manufacturers and retailers to stem the unauthorised production and sales of special foods, including Foods for Special Medical Purpose (FSMPs).
Industry leaders in Australia have hailed cross-party agreement that will lead to five years protection for clinical trials for complementary medicines and supplements, a world-first move that trade body Complementary Medicines Australia (CMA) says will...
The FSSAI has allowed children’s complementary foods companies holding the proprietary license to renew their licenses for a further 12 months, in order to provide more time to meet new standards.
The United States Food and Drug Administration has suspended all inspections of facilities in China in keeping with a State Department travel advisory, the agency announced on Friday.
APAC’s fragmented, and at times volatile, regulatory landscape can be a major headache for supplements and functional foods firms. As we enter 2020, we look at some of the new rules that will commence from January and the developments that are likely...
Australia’s Therapeutic Goods Administration (TGA) is drafting a new regulation which will govern the manufacturing process and uses of faecal microbiota transplant (FMT) products.
The Chinese authorities have proposed five changes to the country’s infant formula milk powder registration process, in a bid to boost the level of quality, scientific evidence, and safe consumption of the products.
The Philippines Food and Drug Administration (FDA) has issued a stern public warning against the purchase and consumption of 11 dietary supplements it has pinpointed as 'unlicensed and unsafe'.
Local authorities may soon address possible 'gaps' in Singapore’s legislation regarding and healthy food products, with regulator Singapore Food Agency (SFA) commissioning a study to assess its rules regime.
Read about who won big at Natural Health Products New Zealand industry awards, China's crackdown on health foods and probiotics regulations, and the latest research and innovations in the Oceanic region.
Read about latest the regulatory developments in China, Blackmores' acerbic response to the MBA's "attack" on complementary medicine, and the mystery of India's missing fortified flour in our regulatory review.
The Medical Board of Australia's (MBA) proposal to reassess the regulation of complementary medicines and practitioners who prescribe them has elicited a strongly worded response from Marcus Blackmore.
The recent slew of crackdowns, regulatory reviews and stricter rules for China's health food and supplement industry are 'growing pains' the industry must overcome, as regulators double down on efforts to promote safety and collect taxes.
China's State Administration for Market Regulation (SAMR) is calling for public feedback regarding regulations for health food products containing probiotics.
China's State Administration for Market Regulation (SAMR) has announced the start of a public consultation to review health food claims, leading to widespread industry uncertainty that regulatory experts claim will hit new product development and...
Domestic infant formula in China may be at its safest and best quality yet, according to industry consensus, following stricter measures implemented by authorities in recent times.
The Food Safety and Standards Association of India (FSSAI) has announced its collaboration with the Ministry of Ayush on possible standards for ayurvedic ahaar, or traditional ayurvedic foods, as a separate category.
Medical marijuana may soon make some progress in India, but any hope of more relaxed regulations on CBD or hemp for nutraceuticals has gone up in smoke, according to one industry expert.
Get our most recent news on nutraceuticals and vitamin C in India, CBD legislation in Australia, India and the Philippines, and Promisia's continued fight against government prosecution regarding its controversial arthritis supplement.
Here's a recap of our 10 most read nutrition stories in February, featuring Blackmores' financials, regulatory news from China, new innovations from Japan, and emerging research from New Zealand and India.
Read about China's continuing '100-day operation', closer inspection of infant formula, and the latest business developments in the country's supplement and health food market in our latest look at China.
Chinese firm Sirio Pharma has had its sports nutrition product licence approved in China, signalling new expansion opportunities for the company and its clients in the country's growing market.
New Zealand's Ministry of Health has announced it is prosecuting Promisia, the manufacturer of arthritis supplement Arthrem, in a move the firm's CEO claims is littered with "significant factual errors".
Pharmaceutical firms are making strides in the Australia's medical cannabis space, but supplement and nutraceutical firms will have to wait a long time before they can do the same, says an industry expert.
Here's a recap of our 10 most read nutrition stories in January, featuring regulatory updates from China and Australia, Nestlé's moves in the A2 milk market, the top APAC supplement trends to watch this year, and more.
China will tighten its inspection of infant formula products that are pending registration approval by conducting more sample testing and on-site inspection.
The Chinese authorities have started a '100-day operation' in a bid to weed out unscrupulous industry practices prevalent in the country's health food market.
Ninety-eight per cent of the approved health food filings in China over the last 18 months went to domestic firms, a Chinese regulatory consultancy has found.
Almost 60% of complementary healthcare practitioners in Australia think recent reforms by the Therapeutic Good Administration (TGA) have had an adverse impact on the industry, according to the regulator's own stakeholder survey.
From revamped regulations in New Zealand and India to controversy surrounding infant formula brands in APAC and a supplement firm in China, this month's regulatory review covers the latest news on ingredient, advertising and manufacturing laws in...
The announcement of New Zealand’s new Therapeutics Products Bill has brought with it hopes that new legislation may finally follow for natural products, with officials noting they are 'considering options' for separate regulations.
Most of the products that have obtained the Foods for Special Medical Purposes (FSMP) registration certificate in China are catered to premature and / or low birth weight infants, and there is a lack of FSMP products for the elderly.
Vietnam is seeing a surge in the volume of counterfeit dietary supplements being sold and consumed, according to the Vietnam Association of Functional Food (VAFF).
Read about Swisse's stellar performance at this year's Singles' Day sales, China's cross-border e-commerce (CBEC) regulations, Biostime's entry into Australia's infant formula market, and Aland's precision nutrition...
New Zealand's Commerce Commission has granted the Infant Nutrition Council (INC) authorisation to extend advertising and marketing restrictions to include infant formula products for children up to one year of age.
Experts gathered to discuss the potential and developments in the probiotics industry, highlighting regulations, trial design and costs as three areas to pay attention to in improving the industry's prospects.
Internal alignment within a nutrition company is just as important as external collaboration, in order to ensure that the regulatory environment is as favourable and effective as possible.
The International Probiotics Association (IPA) has urged the industry to support its efforts to bring consistency to the global regulatory landscape, so that the rules can keep pace with technology and scientific advancement.
Australia's innovation culture and stringent regulatory system are among the reasons Australian companies are thriving in Asia, according to the boss of Life-Space, China's leading probiotic brand.
